Report Library
View More
Schizophrenia and Bipolar Disorder ...
March 24, 2023
Schizophrenia and Bipolar Disorder ...
March 23, 2023
Datamonitor Healthcare Oncology Dis...
March 23, 2023
Datamonitor Healthcare Oncology: NH...
March 23, 2023
Datamonitor Healthcare CV&Met: Amyl...
March 23, 2023
Datamonitor Healthcare CNS: Hunting...
March 23, 2023
Prostate Cancer KOL Interview - Ita...
March 22, 2023
Datamonitor Healthcare I&I: Dry Eye...
March 21, 2023
Datamonitor Healthcare CV&Met Disea...
March 21, 2023
Datamonitor Healthcare Oncology: Ne...
March 21, 2023
Impact Events
More| Date | Lead Company | Event | Type | Approval Change | Approval Likelihood |
|---|---|---|---|---|---|
| 3/23/23 | Sanofi (SNY) | Dupixent for Chronic Obstructive Pulmonary Disease (COPD) | Subscribers Only | Subscribers Only | Subscribers Only |
| 3/22/23 | Biogen (BIIB) | Tofersen for Amyotrophic Lateral Sclerosis (ALS) | Subscribers Only | Subscribers Only | Subscribers Only |
| 3/22/23 | 89bio (ETNB) | BIO89-100 for Non-Alcoholic Steatohepatitis (NASH) | Subscribers Only | Subscribers Only | Subscribers Only |
| 3/21/23 | Swedish Orphan Biovitrum (SOBI) | SEL-212 for Gout | Subscribers Only | Subscribers Only | Subscribers Only |
| 3/21/23 | Altimmune (ALT) | Pemvidutide for Obesity | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range | Lead Company | Drug | Expected Catalyst |
|---|---|---|---|
| 03/23/23 | Subscribers Only | Subscribers Only | Trial Announcement - Initiation |
| 03/24/23 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 03/27/23 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 03/25/23 - 03/28/23 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 03/28/23 | Subscribers Only | Subscribers Only | Trial Data - Top-Line Results |
